Caleres, Inc. (CAL) Stock Price & Analysis
Caleres, Inc. (CAL) closed at USD 13.35 on Thursday, October 22, 2026, up 4.95% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 12.72; the Oct 22, 2026 session ranged USD 12.7–13.37 on volume of 343,375 shares. Market capitalization is $460.64M, with a 52-week range of USD 8.8–15.04 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:12 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CAL.md
Key facts (CAL)
- Last four reported quarters (through Aug 1, 2026): revenue $2.85B, net income $52.6M (1.8% margin), free cash flow $67.3M (SEC filings).
- Valuation: P/E 8.8x (avg 6.3x at the last 2 fiscal year-ends).
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $168K; 0 not under a Rule 10b5-1 plan ($0K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Hold (mean 2.50 on a 1–5 scale) (2 analysts), mean target USD 17 (range 16–18).
- Total return with dividends: 1Y +6.5% vs S&P 500 +14.9%; 5Y -37.9% vs S&P 500 +80.3%.
- Next earnings: 2026-12-10, EPS estimate USD 0.65, revenue estimate $802M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CAL)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $2.78B | $2.97B | $2.82B | $2.72B | $2.76B | $2.85B |
| Gross profit | $1.23B | $1.28B | $1.26B | $1.22B | $1.18B | — |
| Operating income | $206M | $214M | $194M | $150M | $6.4M | $87.0M |
| Net income | $137M | $182M | $171M | $107M | -$6.7M | $52.6M |
| EPS (diluted) | $3.56 | $4.92 | $4.80 | $3.09 | -$0.21 | — |
| Free cash flow | $150M | $70.0M | $156M | $55.4M | $39.4M | $67.3M |
| Gross margin | 44.2% | 43.3% | 44.8% | 44.9% | 43.0% | — |
| Operating margin | 7.4% | 7.2% | 6.9% | 5.5% | 0.2% | 3.1% |
| Net margin | 4.9% | 6.1% | 6.1% | 3.9% | -0.2% | 1.8% |
| Revenue growth | +31.2% | +6.9% | -5.1% | -3.4% | +1.3% | — |
| Cash + short-term investments | $30.1M | $33.7M | $21.4M | $29.6M | $29.8M | — |
| Total debt | $0K | — | — | — | — | — |
Fiscal years end Jan. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Aug 1, 2026) (CAL)
P/E 8.8x · P/S 0.2x · P/FCF 6.8x · P/B 0.7x · FCF yield 14.62% · Earnings yield 11.41% · Dividend yield (paid, TTM) 2.06% · Buyback yield (TTM) 0.68%
P/E at fiscal year-ends: Feb 2025 5.0x, Feb 2024 7.7x.
Insider sales (SEC Form 4, open-market, last ~7 months) (CAL)
1 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Freidman Daniel R | Chief Sourcing Officer | 11,207 | $168K | 13.4% | Yes (adopted December 16, 2025) | Too little history (no open-market trades in 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (CAL)
Consensus Hold (mean 2.50 on a 1–5 scale), 2 analysts; mean target USD 17 (low 16, high 18).
Total return (dividends reinvested) (CAL)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +6.5% | -37.9% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +6.5% | -9.1% |
| Volatility (annualized) | 63.2% | 53.1% |
| Max drawdown | -36.9% (Jan 2026→Mar 2026) | -78.3% (Aug 2024→Mar 2026) |
CAL analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Oct 2026) | $0.65 | $0.84 | -22.2% | $801.8M | 3 |
| Next quarter (ends Jan 2027) | $0.10 | $0.05 | +100.0% | $700.8M | 3 |
| Current fiscal year (ends Jan 2027) | $1.61 | $1.63 | -1.2% | $2.86B | 3 |
| Next fiscal year (ends Jan 2028) | $2.19 | $2.28 | -3.7% | $2.95B | 3 |
Key Statistics (as of October 23, 2026 at 10:12 UTC)
| Price | USD 13.35 |
|---|---|
| Change | ▲ 4.95% (up) |
| Previous Close | USD 12.72 |
| Open | USD 12.64 |
| Day Range | USD 12.7 – 13.37 |
| 52-Week Range | USD 8.8 – 15.04 |
| Volume | 343,375 shares |
| Market Cap | $460.64M |
| Exchange | NYQ |
Technical Analysis (CAL)
Nexqual's technical model rates CAL "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 10:12 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 61.7 (neutral) |
| vs SMA50 | Above (USD 12.57) |
| MACD | 0.14 (positive) |
Analyst Ratings (CAL)
Wall Street analysts rate CAL "Hold" based on 2 analysts, with a mean price target of USD 17 (range USD 16–18), per Nexqual as of October 23, 2026 at 10:12 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 17 |
| High Target | USD 18 |
| Low Target | USD 16 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (CAL)
| Next Earnings Date | 2026-12-10 |
|---|---|
| EPS Estimate | USD 0.65 |
| Revenue Estimate | $801.77M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-07-31 | USD 0.47 vs est 0.37 ▲ beat |
| 2026-04-30 | USD 0.38 vs est 0.37 ▲ beat |
| 2026-01-31 | USD -0.06 vs est -0.4 ▲ beat |
| 2025-10-31 | USD 0.38 vs est 0.85 ▼ miss |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financials & Fundamentals (CAL)
| Total Revenue | $2.85B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +5.60% |
| Gross Margin | +44.83% |
| Operating Margin | +3.35% |
| Profit Margin | +1.85% |
| ROE | +7.71% |
| Debt / Equity | 1.29 |
| Current Ratio | 1.11 |
| Total Cash | $50.92M |
| Total Debt | $877.31M |
| Free Cash Flow (last four quarters to Aug 2026, SEC 10-Q / 10-K) | $67.34M (2.4% of revenue) |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financial Health Score (CAL)
Nexqual rates Caleres, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:12 UTC.
| Growth | Mixed — Revenue +1.3% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 45%, operating 3% (last 12 months) |
| Balance Sheet | Mixed — $51M cash vs $877M debt |
| Cash Flow | Mixed — FCF $67M (last 4 quarters to Aug 2026, SEC), slim 2.4% margin |
| Efficiency | Mixed — ROE 8%, ROA 1.8% |
Ownership (CAL)
| Insider Ownership | +4.42% |
|---|---|
| Institutional Ownership | +89.20% |
| Shares Outstanding | 34.50M |
| Float | 32.72M |
| Short % of Float | +12.03% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Leadership (CAL)
Caleres, Inc. is led by John W. Schmidt, President, CEO & Director, per Nexqual as of October 23, 2026 at 10:12 UTC.
| President, CEO & Director | John W. Schmidt |
|---|---|
| Senior VP & CFO | Daniel L. Karpel |
| Division President of Famous Footwear | Brian P. Costello |
| Vice President of Investor Relations | Logan Bonacorsi |
| Senior Vice President of Corporate Development & Strategic Communications | Lizabeth Dunn |
Major Backers & Investors (CAL)
Notable institutional backers of Caleres, Inc. include FMR, LLC, Fidelity, American Century Companies Inc, according to Nexqual as of October 23, 2026 at 10:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 14.6% |
| Fidelity | 9.08% |
| American Century Companies Inc | 3.82% |
| Neuberger Berman Group, LLC | 3.68% |
| Arrowstreet Capital, Limited Partnership | 2.66% |
| Invenomic Capital Management, LP | 2.62% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 11.45% |
| Vanguard Group | 4.16% |
| Dimensional Fund Advisors | 3.65% |
| State Street | 2.97% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GCO | Genesco Inc. | USD 37.39 | ▲ 3.2% |
| SHOE | Shoe Station Group, Inc. | USD 14.22 | ▲ 7.56% |
| CTRN | Citi Trends, Inc. | USD 46 | ▲ 0.17% |
| SFIX | Stitch Fix, Inc. | USD 2.72 | ▲ 5.63% |
| JILL | J. Jill, Inc. | USD 22.85 | ▼ 2.02% |
| REF | Reformation Inc. | USD 15.03 | ▲ 7.43% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:12 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt